These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 25200966)

  • 1. Neurotensin signaling regulates stem-like traits of glioblastoma stem cells through activation of IL-8/CXCR1/STAT3 pathway.
    Zhou J; Yi L; Ouyang Q; Xu L; Cui H; Xu M
    Cell Signal; 2014 Dec; 26(12):2896-902. PubMed ID: 25200966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRIM8 regulates stemness in glioblastoma through PIAS3-STAT3.
    Zhang C; Mukherjee S; Tucker-Burden C; Ross JL; Chau MJ; Kong J; Brat DJ
    Mol Oncol; 2017 Mar; 11(3):280-294. PubMed ID: 28100038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurotensin signaling stimulates glioblastoma cell proliferation by upregulating c-Myc and inhibiting miR-29b-1 and miR-129-3p.
    Ouyang Q; Chen G; Zhou J; Li L; Dong Z; Yang R; Xu L; Cui H; Xu M; Yi L
    Neuro Oncol; 2016 Feb; 18(2):216-26. PubMed ID: 26180082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the STAT3 inhibitor STX-0119 on the proliferation of cancer stem-like cells derived from recurrent glioblastoma.
    Ashizawa T; Miyata H; Iizuka A; Komiyama M; Oshita C; Kume A; Nogami M; Yagoto M; Ito I; Oishi T; Watanabe R; Mitsuya K; Matsuno K; Furuya T; Okawara T; Otsuka M; Ogo N; Asai A; Nakasu Y; Yamaguchi K; Akiyama Y
    Int J Oncol; 2013 Jul; 43(1):219-27. PubMed ID: 23612755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of STAT3 expression by RNAi suppresses growth and induces apoptosis and differentiation in glioblastoma stem cells.
    Li GH; Wei H; Lv SQ; Ji H; Wang DL
    Int J Oncol; 2010 Jul; 37(1):103-10. PubMed ID: 20514402
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BIS-mediated STAT3 stabilization regulates glioblastoma stem cell-like phenotypes.
    Im CN; Yun HH; Song B; Youn DY; Cui MN; Kim HS; Park GS; Lee JH
    Oncotarget; 2016 Jun; 7(23):35056-70. PubMed ID: 27145367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tetraspanin CD9 stabilizes gp130 by preventing its ubiquitin-dependent lysosomal degradation to promote STAT3 activation in glioma stem cells.
    Shi Y; Zhou W; Cheng L; Chen C; Huang Z; Fang X; Wu Q; He Z; Xu S; Lathia JD; Ping Y; Rich JN; Bian XW; Bao S
    Cell Death Differ; 2017 Jan; 24(1):167-180. PubMed ID: 27740621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular heterogeneity in a patient-derived glioblastoma xenoline is regulated by different cancer stem cell populations.
    Garner JM; Ellison DW; Finkelstein D; Ganguly D; Du Z; Sims M; Yang CH; Interiano RB; Davidoff AM; Pfeffer LM
    PLoS One; 2015; 10(5):e0125838. PubMed ID: 25955030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tanshinone IIA inhibits the growth, attenuates the stemness and induces the apoptosis of human glioma stem cells.
    Yang L; Guo H; Dong L; Wang L; Liu C; Wang X
    Oncol Rep; 2014 Sep; 32(3):1303-11. PubMed ID: 24970314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of a novel therapeutic target for head and neck squamous cell carcinomas: a role for the neurotensin-neurotensin receptor 1 oncogenic signaling pathway.
    Shimizu S; Tsukada J; Sugimoto T; Kikkawa N; Sasaki K; Chazono H; Hanazawa T; Okamoto Y; Seki N
    Int J Cancer; 2008 Oct; 123(8):1816-23. PubMed ID: 18661521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenovirus infection promotes the formation of glioma stem cells from glioblastoma cells through the TLR9/NEAT1/STAT3 pathway.
    Zang J; Zheng MH; Cao XL; Zhang YZ; Zhang YF; Gao XY; Cao Y; Shi M; Han H; Liang L
    Cell Commun Signal; 2020 Aug; 18(1):135. PubMed ID: 32843056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Novel Positive Feedback Loop Between NTSR1 and Wnt/β-Catenin Contributes to Tumor Growth of Glioblastoma.
    Xiao H; Zeng Y; Wang Q; Wei S; Zhu X
    Cell Physiol Biochem; 2017; 43(5):2133-2142. PubMed ID: 29065410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methylation by EZH2 activates STAT3 in glioblastoma.
    Cancer Discov; 2013 Jul; 3(7):OF21. PubMed ID: 23847365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of type I interferon on glioblastoma cancer stem cells.
    Du Z; Cai C; Sims M; Boop FA; Davidoff AM; Pfeffer LM
    Biochem Biophys Res Commun; 2017 Sep; 491(2):343-348. PubMed ID: 28728846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
    Leidgens V; Proske J; Rauer L; Moeckel S; Renner K; Bogdahn U; Riemenschneider MJ; Proescholdt M; Vollmann-Zwerenz A; Hau P; Seliger C
    Oncotarget; 2017 Jan; 8(5):8250-8263. PubMed ID: 28030813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis.
    Chen X; Hao A; Li X; Du Z; Li H; Wang H; Yang H; Fang Z
    J Pineal Res; 2016 Sep; 61(2):208-17. PubMed ID: 27121240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-8, but not the Related Chemokine CXCL1, Sustains an Autocrine Circuit Necessary for the Properties and Functions of Thyroid Cancer Stem Cells.
    Liotti F; Collina F; Pone E; La Sala L; Franco R; Prevete N; Melillo RM
    Stem Cells; 2017 Jan; 35(1):135-146. PubMed ID: 27577959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PDGFRα depletion attenuates glioblastoma stem cells features by modulation of STAT3, RB1 and multiple oncogenic signals.
    Cenciarelli C; Marei HE; Felsani A; Casalbore P; Sica G; Puglisi MA; Cameron AJ; Olivi A; Mangiola A
    Oncotarget; 2016 Aug; 7(33):53047-53063. PubMed ID: 27344175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coculture with astrocytes reduces the radiosensitivity of glioblastoma stem-like cells and identifies additional targets for radiosensitization.
    Rath BH; Wahba A; Camphausen K; Tofilon PJ
    Cancer Med; 2015 Nov; 4(11):1705-16. PubMed ID: 26518290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of EGFR, HER2 and HER3 by neurotensin/neurotensin receptor 1 renders breast tumors aggressive yet highly responsive to lapatinib and metformin in mice.
    Dupouy S; Doan VK; Wu Z; Mourra N; Liu J; De Wever O; Llorca FP; Cayre A; Kouchkar A; Gompel A; Forgez P
    Oncotarget; 2014 Sep; 5(18):8235-51. PubMed ID: 25249538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.